Mind + Machines Group has released an update on their trading for the beginning of 2019, which, most notably, has featured a 38% increase in domain registrations to 1.84 million year-on-year with steady growth.
The company reported that billings are also up, a significant 129% year-on-year, as a result of the first time ICM contribution and a notable increase in billings in China, which went up over 40%.
The surge in billing has been propelled by .luxe registrations and continuing .vip sales. The group’s .law and US portfolio also brought in encouraging numbers, up over 9% compared to the same period last year.
MMX directors also reported that ICM has completed its first annual renewals cycle on their main property, with renewal rates exceeding management expectations at 91%.
According to the group, these new registrations within ICM are reflective of “initiatives that have been put in place since ICM was acquired by the Company to drive new registrations and usage of ICM properties.”
MMX has also provided an update on the group’s integration of bitcoin into the .luxe R&D project.
The company has partnered with the lead developers of the Namecoin blockchain and XAYA platform to develop an “easy-to-use naming solution that will integrate human readable .luxe addresses with bitcoin alphanumeric addresses in a fully secure and decentralised fashion.”
This feature will allow uses to securely associate .luxe names with Ethereum alphanumeric addresses but also to bitcoin ones, such as their own bitcoin wallet. The company expects this new update to go live in H2 2019.
Lastly, the company also provided a report on their current cash position and loan repayment. At the end of 2018, MMX’s cash balances stood at $10.4 million. 2019 has seen that cash balance grow to $11.9 million by February 25th.
With this encouraging start to the year, the company believes “the entirety of the outstanding debt of $2.3 million under the London & Capital facility will be repaid early in March 2019, leaving the Company debt free.”
For more news and updates on:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
(Sharecast News) - Stocks in London finished in the green on Monday, helped by the release of a much better than expected reading on euro area factory activity last month, and similarly upbeat survey results overnight in China.
Seeing Machines said total income, revenue and cash are ahead of market expectations for the period ended 30 June 2020. The driver monitoring system technology company said it continues to deliver its products across several industries despite the effects of the COVID-19 pandemic.
Union Jack Oil has a further 12.5% interest in PEDL180 and PEDL182 from Humber Oil & Gas, which the group says will have ‘an immediate positive by increasing its reserves and resources at Wressle by 45.5% to 1.24 million barrels of oil equivalent.
Versarien has today announced the launch of its first Graphene Enhanced Protective Face Mask, which utilises Polygrene, Versarien's graphene enhanced polymer to protect against airborne bacteria and minimise the spread of viral infection.
(Sharecast News) - Stocks in London are on the back foot at the start of August, weighed down by a retreat in lenders' shares and reports pointing to increasing odds that stricter Covid-19 restrictions were in the pipeline, both in the UK and the US.
New "life-saving" 90-minute tests which can detect coronavirus and flu will be rolled out in care homes and laboratories from next week. The "on-the-spot" swab and DNA tests will help distinguish between Covid-19 and other seasonal illnesses, the government said.